GDF5 rs143384: Joint Health and Cartilage Genetics
The rs143384 variant is a common single nucleotide polymorphism located in the 5' untranslated region (5' UTR) of the GDF5 gene. This regulatory variant modulates the expression of growth differentiation factor 5, a protein essential for cartilage repair, bone morphology, and joint maintenance. Research links this variant to modest variations in joint development, exercise-related joint strain, and osteoarthritis risk.
What each genotype means
Baseline joint development profile
This genotype represents the major allele configuration associated with standard GDF5 expression levels in cartilage. Research suggests this profile is generally associated with a lower risk of osteoarthritis compared to carriers of the T allele, though individual risk is influenced by many environmental and lifestyle factors.
This is the most common genotype in many European populations, while it is less frequent in East Asian populations where the T allele is more prevalent.
Intermediate joint risk profile
Carrying one copy of the T allele is associated with altered GDF5 expression, which may influence cartilage homeostasis and joint health. Studies indicate that this genotype confers an intermediate risk for osteoarthritis, with some evidence suggesting that the impact of this variant on joint health can vary significantly based on body mass index and physical activity levels.
This heterozygous genotype is found at high frequencies globally, reflecting the common nature of the T allele in many ancestral groups.
Increased joint susceptibility profile
The TT genotype is associated with reduced GDF5 protein expression in joint tissues, which may affect cartilage repair and mechanical resilience. While this genotype is statistically linked to an increased risk of osteoarthritis in many studies, the effect is complex and can be modified by factors such as obesity and specific joint-loading patterns.
This genotype is common in East Asian populations and is also frequently observed in European populations.
Genetic Location and Regulatory Function
The single nucleotide polymorphism rs143384 is situated in the 5' untranslated region (5' UTR) of the growth differentiation factor 5 (GDF5) gene, located on chromosome 20. Depending on whether researchers report the forward or reverse genomic strand, the alternate alleles are typically described as C/T or G/A. Because it resides in a non-coding regulatory segment, rs143384 does not alter the protein sequence of GDF5 directly. Instead, functional studies demonstrate that it influences transcriptional activity. The minor allele (frequently noted as T on the forward strand, or A on the reverse strand) reduces promoter efficiency by altering transcription factor binding sites and CpG methylation dynamics. Furthermore, rs143384 exists in high linkage disequilibrium with another widely studied promoter variant, rs143383. Together, these regulatory variants modulate messenger RNA transcription levels in joint tissues.
The Biological Role of GDF5 in Joint Homeostasis
The GDF5 gene encodes growth differentiation factor 5, a key member of the bone morphogenetic protein (BMP) and transforming growth factor-beta (TGF-beta) superfamily. During embryonic and postnatal development, GDF5 provides critical biochemical signals that orchestrate joint interzone formation, bone shape patterning, and tendon-to-bone attachment. In adult joints, GDF5 continues to serve an indispensable maintenance role within articular cartilage and the synovial lining. It stimulates chondrocyte proliferation, encourages the synthesis of extracellular matrix components like type II collagen and proteoglycans, and aids in joint tissue repair following mechanical stress or minor micro-trauma. When regulatory variants decrease GDF5 production, articular cartilage exhibits reduced anabolic capacity, leaving joint structures more vulnerable to progressive thinning and degenerative remodeling under repetitive mechanical loads.
Scientific Evidence and Phenotypic Associations
A broad body of genome-wide association studies (GWAS) and candidate gene analyses has evaluated rs143384 across diverse populations. The variant's lower-expression allele has been correlated with increased susceptibility to knee and hip osteoarthritis, developmental dysplasia of the hip, and slight reductions in adult height. However, the overall strength of evidence for clinical prediction remains limited. Individual effect sizes are modest, typically presenting odds ratios between 1.1 and 1.4 for musculoskeletal degeneration. Furthermore, the clinical impact of rs143384 is strongly modified by non-genetic factors such as biological sex, age, mechanical strain, and body mass index (BMI). Some investigations note that carrying the risk-associated allele predominantly impacts joint outcomes in individuals subjected to chronic joint overload, illustrating complex gene-environment interactions.
Ancestry and Global Distribution
The frequency of the rs143384 regulatory allele varies significantly across global human populations. In European-ancestry cohorts, the minor allele frequency is approximately 0.40, making heterozygous and homozygous carriers relatively widespread. In East Asian populations, the variant allele is considerably more prevalent, reaching frequencies of approximately 0.65. Cohorts with admixed genetic backgrounds, such as Latin American populations, display intermediate frequencies that reflect complex ancestral contributions from European, Indigenous American, and African lineages. Because background haplotype architectures and environmental risk factors differ across ancestries, the statistical correlations between rs143384 and clinical joint phenotypes cannot be assumed to produce identical health outcomes across all global populations.
Practical Implications and Clinical Perspective
Understanding your rs143384 genotype provides an interesting perspective on joint biology, but it cannot be used to diagnose or predict osteoarthritis. Multifactorial joint disorders arise from complex interactions involving hundreds of small-effect genetic variants alongside powerful lifestyle determinants. Carrying one or two copies of the lower-expression allele does not guarantee cartilage degeneration, nor does carrying the protective genotype ensure immunity from joint injury. High-impact preventive strategies—such as maintaining a healthy body weight, engaging in low-impact resistance and mobility exercises to support stabilizing musculature, and avoiding unaddressed repetitive strain—remain the primary determinants of joint longevity regardless of individual genetic markers.
How common is this variant?
The rs143384 lower-expression T allele occurs at a frequency of approximately 0.40 in European populations and reaches roughly 0.65 in East Asian populations, with intermediate frequencies observed in admixed cohorts.
Frequently asked questions
Does having the rs143384 risk genotype mean I will get osteoarthritis?
No. The rs143384 variant confers only a modest statistical predisposition and is not a deterministic or diagnostic marker. Many individuals with the variant never develop joint disease, as major risk factors like body weight, joint alignment, prior injuries, and general physical fitness play larger roles.
Can I test for rs143384 to guide my workout routine?
Direct-to-consumer genetic panels frequently report rs143384 under musculoskeletal categories, but there are no clinical guidelines recommending specific exercise adjustments based on this SNP alone. Standard sports medicine advice—such as gradual training progression, proper biomechanics, and incorporating strength training to support the joints—applies equally across all genotypes.
Why do some scientific studies call this variant G and A instead of C and T?
Genetic sequencing can be reported from either the forward or reverse strand of DNA. The C/T alleles on one strand correspond directly to the G/A alleles on the complementary strand, meaning that a C allele corresponds to G, and a T allele corresponds to A.
Can taking collagen or joint supplements reverse the effect of this variant?
There is no clinical evidence demonstrating that dietary supplements can alter GDF5 gene expression or compensate specifically for the rs143384 polymorphism. If you experience persistent joint pain, discomfort, or functional limitations, consult a healthcare professional for an evidence-based clinical evaluation.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs143384?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29